Hemophilia of Georgia Center for Bleeding & Clotting Disorders

Atlanta, Georgia 30308

0 studies enrolling now · 1 studies all time

What they study most

Hemophilia A, Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor

Studies at this site

• A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors — Completed